Vida raises $11M to commercialize AI lung software

2017 12 20 17 16 6396 Lung General 400

Lung imaging software developer Vida Diagnostics has raised $11 million to help with the commercialization of its artificial intelligence (AI)-powered lung analysis software, LungPrint.

First Analysis Corporation led the funding round, with equity participation from Blue Heron Capital and UnityPoint Health Ventures. The company also received support from NextLevel Ventures, Chartline Capital Partners, Rural Vitality Fund, Rittenhouse Ventures, Iowa First Capital Fund, and the Angels' Forum.

Page 1 of 365
Next Page